IP Library › Granted Patent US 12,329,158
Granted Patent B2
US 12,329,158 · App. 18/373,376 · Granted Jun 17, 2025

Large-scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness

Inventors: Daniel MacLean (Woodland, CA); Richard M. Jacobson (Chalfont, PA); Timothy Malefyt (Stroudsburg, PA)
Assignee: AGROFRESH INC.
A01N55/08A01N25/18A01N55/00A23B2/721A23B4/16A23B4/20A23B7/152A23B7/154A61K9/0034A61K9/70A61K31/69
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,329,158
App. No.
18/373,376
Granted
Jun 17, 2025
Kind
B2
Abstract

The present application relates to large-scale methods of uniformly coating packaging surfaces with a benzoxaborole compound.

Claims (92)

1. A method of treating a food packaging material with an antimicrobial agent, the method comprising:

administering a benzoxaborole treatment to one or more surfaces of the food packaging material, wherein the benzoxaborole treatment comprises one or more benzoxaborole compounds,

drying the one or more surfaces of the food packaging material,

placing a food product inside of the food packaging material,

wherein the one or more benzoxaborole compounds are:

i) of formula (IV), or a salt thereof:

wherein A and D together with the carbon atoms to which they are attached form a 5-, 6-, or 7-membered fused ring which may be substituted by C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, hydroxy, halogen, nitro, nitrile, amino, amino substituted by one or more C 1 -C 6 -alkyl groups, carboxy, acyl, aryloxy, carbonamido, carbonamido substituted by C 1 -C 6 -alkyl, sulfonamido or trifluoromethyl or the fused ring may link two oxaborole rings;

X is a group —CR 7 R 8 wherein R 7 and R 8 are each independently hydrogen, C 1 -C 6 -alkyl, nitrile, nitro, aryl, arylalkyl or R 7 and R 8 together with the carbon atom to which they are attached form an alicyclic ring; and

R 6 is hydrogen, C 1 -C 18 -alkyl, C 1 -C 18 -alkyl substituted by C 1 -C 6 -alkoxy, C 1 -C 6 -alkylthio, hydroxy, amino, amino substituted by C 1 -C 18 -alkyl, carboxy, aryl, aryloxy, carbonamido, carbonamido substituted by C 1 -C 6 -alkyl, aryl or arylalkyl, arylalkyl, aryl, heteroaryl, cycloalkyl, C 1 -C 18 -alkyleneamino, C 1 -C 18 -alkyleneamino substituted by phenyl, C 1 -C 6 -alkoxy or C 1 -C 6 -alkylthio, carbonyl alkyleneamino or a radical of formula (V):

wherein A, D and X are as defined herein before, or

ii) formula (A):

R A -L A -G-L B -R B   (A),

wherein

each of R A and R B is independently a of R A and R B is of formula (E):

wherein each R 6 is independently hydrogen, alkyl, alkene, alkyne, haloalkyl, haloalkene, haloalkyne, alkoxy, alkeneoxy, haloalkoxy, aryl, heteroaryl, arylalkyl, arylalkene, arylalkyne, heteroarylalkyl, heteroarylalkene, heteroarylalkyne, halogen, hydroxyl, nitrile, amine, ester, carboxylic acid, ketone, alcohol, sulfide, sulfoxide, sulfone, sulfoximine, sulfilimine, sulfonamide, sulfate, sulfonate, nitroalkyl, amide, oxime, imine, hydroxylamine, hydrazine, hydrazone, carbamate, thiocarbamate, urea, thiourea, carbonate, aryloxy, or heteroaryloxy;

n=1, 2, 3, or 4;

B is boron;

X 2 =(CR 6 2 ) m where m=1 or 2;

each of L A and L B is independently —O— or

each of R and R′ is independently hydrogen, unsubstituted or substituted C 1-18 -alkyl, arylalkyl, aryl, or heterocyclic moiety; and

G is a substituted or unsubstituted C 1-18 -alkylene, arylalkylene, arylene, or heterocyclic moiety; and acceptable salts thereof.

2. The method of claim 1 , wherein the food product is selected from the group consisting of a strawberry, a raspberry, a blackberry, and a blueberry.

3. The method of claim 1 , wherein the benzoxaborole is of formula (IV), or a salt thereof:

wherein A and D together with the carbon atoms to which they are attached form a 5-, 6-, or 7-membered fused ring which may be substituted by C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, hydroxy, halogen, nitro, nitrile, amino, amino substituted by one or more C 1 -C 6 -alkyl groups, carboxy, acyl, aryloxy, carbonamido, carbonamido substituted by C 1 -C 6 -alkyl, sulfonamido or trifluoromethyl or the fused ring may link two oxaborole rings;

X is a group —CR 7 R 8 wherein R 7 and R 8 are each independently hydrogen, C 1 -C 6 -alkyl, nitrile, nitro, aryl, arylalkyl or R 7 and R 8 together with the carbon atom to which they are attached form an alicyclic ring; and

R 6 is hydrogen, C 1 -C 18 -alkyl, C 1 -C 18 -alkyl substituted by C 1 -C 6 -alkoxy, C 1 -C 6 -alkylthio, hydroxy, amino, amino substituted by C 1 -C 18 -alkyl, carboxy, aryl, aryloxy, carbonamido, carbonamido substituted by C 1 -C 6 -alkyl, aryl or arylalkyl, arylalkyl, aryl, heteroaryl, cycloalkyl, C 1 -C 18 -alkyleneamino, C 1 -C 18 -alkyleneamino substituted by phenyl, C 1 -C 6 -alkoxy or C 1 -C 6 -alkylthio, carbonyl alkyleneamino or a radical of formula (V):

wherein A, D and X are as defined herein before.

4. The method of claim 3 , wherein the benzoxaborole compound is has the structure

or a salt thereof.

5. The method of claim 1 , wherein the benzoxaborole has the structure formula (A):

R A -L A -G-L B -R B   (A),

wherein

each of R A and R B is independently a of R A and R B is of formula (E):

wherein each R 6 is independently hydrogen, alkyl, alkene, alkyne, haloalkyl, haloalkene, haloalkyne, alkoxy, alkeneoxy, haloalkoxy, aryl, heteroaryl, arylalkyl, arylalkene, arylalkyne, heteroarylalkyl, heteroarylalkene, heteroarylalkyne, halogen, hydroxyl, nitrile, amine, ester, carboxylic acid, ketone, alcohol, sulfide, sulfoxide, sulfone, sulfoximine, sulfilimine, sulfonamide, sulfate, sulfonate, nitroalkyl, amide, oxime, imine, hydroxylamine, hydrazine, hydrazone, carbamate, thiocarbamate, urea, thiourea, carbonate, aryloxy, or heteroaryloxy;

n=1, 2, 3, or 4;

B is boron;

X 2 =(CR 6 2 ) m where m=1 or 2;

each of L A and L B is independently —O— or

each of R and R′ is independently hydrogen, unsubstituted or substituted C 1-18 -alkyl, arylalkyl, aryl, or heterocyclic moiety; and

G is a substituted or unsubstituted C 1-18 -alkylene, arylalkylene, arylene, or heterocyclic moiety; and acceptable salts thereof.

6. The method of claim 3 , wherein the benzoxaborole has the structure

or a salt thereof.

7. The method of claim 1 , wherein administering the benzoxaborole treatment to food packaging material comprises embedding the benzoxaborole compound into the food packaging material, impregnating the food packaging material with the benzoxaborole compound, or coating the food packaging material with the benzoxaborole compound.

8. The method of claim 1 , wherein the food packaging material is a chamber.

9. The method of claim 8 , wherein the chamber is a clamshell.

10. The method of claim 9 , wherein the clamshell comprises polyethylene terephthalate.

11. A large-scale method of treating a plurality of chambers with an antimicrobial agent, the method comprising:

placing a plurality of chambers in a position to be treated wherein each of the chambers comprise one or more surfaces,

administering the antimicrobial treatment to one or more surfaces of the plurality of chambers during preformation, formation, or postformation of the plurality of chambers, wherein the antimicrobial treatment comprises one or more benzoxaborole compounds,

drying the one or more surfaces of the plurality of chambers, and affixing the benzoxaborole compound to the one or more surfaces of the plurality of chambers,

wherein the one or more benzoxaborole compounds are:

i) of formula (IV), or a salt thereof:

wherein A and D together with the carbon atoms to which they are attached form a 5-, 6-, or 7-membered fused ring which may be substituted by C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, hydroxy, halogen, nitro, nitrile, amino, amino substituted by one or more C 1 -C 6 -alkyl groups, carboxy, acyl, aryloxy, carbonamido, carbonamido substituted by C 1 -C 6 -alkyl, sulfonamido or trifluoromethyl or the fused ring may link two oxaborole rings;

X is a group —CR 7 R 8 wherein R 7 and R 8 are each independently hydrogen, C 1 -C 6 -alkyl, nitrile, nitro, aryl, arylalkyl or R 7 and R 8 together with the carbon atom to which they are attached form an alicyclic ring; and

R 6 is hydrogen, C 1 -C 18 -alkyl, C 1 -C 18 -alkyl substituted by C 1 -C 6 -alkoxy, C 1 -C 6 -alkylthio, hydroxy, amino, amino substituted by C 1 -C 18 -alkyl, carboxy, aryl, aryloxy, carbonamido, carbonamido substituted by C 1 -C 6 -alkyl, aryl or arylalkyl, arylalkyl, aryl, heteroaryl, cycloalkyl, C 1 -C 18 -alkyleneamino, C 1 -C 18 -alkyleneamino substituted by phenyl, C 1 -C 6 -alkoxy or C 1 -C 6 -alkylthio, carbonyl alkyleneamino or a radical of formula (V):

wherein A, D and X are as defined herein before, or

ii) formula (A):

R A -L A -G-L B -R B   (A),

wherein

each of R A and R B is independently a of R A and R B is of formula (E):

wherein each R 6 is independently hydrogen, alkyl, alkene, alkyne, haloalkyl, haloalkene, haloalkyne, alkoxy, alkeneoxy, haloalkoxy, aryl, heteroaryl, arylalkyl, arylalkene, arylalkyne, heteroarylalkyl, heteroarylalkene, heteroarylalkyne, halogen, hydroxyl, nitrile, amine, ester, carboxylic acid, ketone, alcohol, sulfide, sulfoxide, sulfone, sulfoximine, sulfilimine, sulfonamide, sulfate, sulfonate, nitroalkyl, amide, oxime, imine, hydroxylamine, hydrazine, hydrazone, carbamate, thiocarbamate, urea, thiourea, carbonate, aryloxy, or heteroaryloxy;

n=1, 2, 3, or 4;

B is boron;

X 2 =(CR 6 2 ) m where m=1 or 2;

each of L A and L B is independently —O— or

each of R and R′ is independently hydrogen, unsubstituted or substituted C 1-18 -alkyl, arylalkyl, aryl, or heterocyclic moiety; and

G is a substituted or unsubstituted C 1-18 -alkylene, arylalkylene, arylene, or heterocyclic moiety; and acceptable salts thereof.

12. The method of claim 11 , wherein the benzoxaborole is of formula (IV), or a salt thereof:

wherein A and D together with the carbon atoms to which they are attached form a 5-, 6-, or 7-membered fused ring which may be substituted by C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, hydroxy, halogen, nitro, nitrile, amino, amino substituted by one or more C 1 -C 6 -alkyl groups, carboxy, acyl, aryloxy, carbonamido, carbonamido substituted by C 1 -C 6 -alkyl, sulfonamido or trifluoromethyl or the fused ring may link two oxaborole rings;

X is a group —CR 7 R 8 wherein R 7 and R 8 are each independently hydrogen, C 1 -C 6 -alkyl, nitrile, nitro, aryl, arylalkyl or R 7 and R 8 together with the carbon atom to which they are attached form an alicyclic ring; and

R 6 is hydrogen, C 1 -C 18 -alkyl, C 1 -C 18 -alkyl substituted by C 1 -C 6 -alkoxy, C 1 -C 6 -alkylthio, hydroxy, amino, amino substituted by C 1 -C 18 -alkyl, carboxy, aryl, aryloxy, carbonamido, carbonamido substituted by C 1 -C 6 -alkyl, aryl or arylalkyl, arylalkyl, aryl, heteroaryl, cycloalkyl, C 1 -C 18 -alkyleneamino, C 1 -C 18 -alkyleneamino substituted by phenyl, C 1 -C 6 -alkoxy or C 1 -C 6 -alkylthio, carbonyl alkyleneamino or a radical of formula (V):

wherein A, D and X are as defined herein before.

13. The method of claim 12 , wherein the benzoxaborole compound is has the structure

or a salt thereof.

14. The method of claim 11 , wherein the benzoxaborole has the structure formula (A):

R A -L A -G-L B -R B   (A),

wherein

each of R A and R B is independently a of R A and R B is of formula (E):

wherein each R 6 is independently hydrogen, alkyl, alkene, alkyne, haloalkyl, haloalkene, haloalkyne, alkoxy, alkeneoxy, haloalkoxy, aryl, heteroaryl, arylalkyl, arylalkene, arylalkyne, heteroarylalkyl, heteroarylalkene, heteroarylalkyne, halogen, hydroxyl, nitrile, amine, ester, carboxylic acid, ketone, alcohol, sulfide, sulfoxide, sulfone, sulfoximine, sulfilimine, sulfonamide, sulfate, sulfonate, nitroalkyl, amide, oxime, imine, hydroxylamine, hydrazine, hydrazone, carbamate, thiocarbamate, urea, thiourea, carbonate, aryloxy, or heteroaryloxy;

n=1, 2, 3, or 4;

B is boron;

X 2 =(CR 6 2 ) m where m=1, 2, 3, or 4;

each of L A and L B is independently —O— or

each of R and R′ is independently hydrogen, unsubstituted or substituted C 1-18 -alkyl, arylalkyl, aryl, or heterocyclic moiety; and

G is a substituted or unsubstituted C 1-18 -alkylene, arylalkylene, arylene, or heterocyclic moiety; and acceptable salts thereof.

15. The method of claim 14 , wherein the benzoxaborole has the structure

or a salt thereof.

16. The method of claim 11 , wherein administering the benzoxaborole treatment to the one or more surfaces of the plurality of chambers during preformation, formation, or postformation of the plurality of chambers further comprises embedding the benzoxaborole compound into the food packaging material, impregnating the food packaging material with the benzoxaborole compound, or coating the food packaging material with the benzoxaborole compound.

17. The method of claim 11 , wherein the one or more surfaces of the plurality of chambers further comprise a liquid-absorbing material.

18. The method of claim 17 , wherein the liquid-absorbing material provides for quick-release or slow-release of the benzoxaborole treatment over a time period.

19. The method of claim 11 , wherein the plurality of chambers are a plurality of clamshells.

20. The method of claim 19 , wherein the plurality of clamshells comprise polyethylene terephthalate.

Continuity (15)
Continuation 17346446 · Jun 14, 2021
Continuation 16707516 · Dec 9, 2019
Continuation In Part 16123735 · Sep 6, 2018
Continuation 15445247 · Feb 28, 2017
Continuation In Part 14690929 · Apr 20, 2015
Continuation In Part 14294057 · Jun 2, 2014
Continuation 14167093 · Jan 29, 2014
Continuation In Part 14182793 · Feb 18, 2014
Division 13945577 · Jul 18, 2013
Continuation In Part 15485500 · Apr 12, 2017
Provisional Application 61991821 · May 12, 2014
Provisional Application 61758313 · Jan 30, 2013
Provisional Application 61831187 · Jun 5, 2013
Provisional Application 62323247 · Apr 15, 2016
Related Publication 20240049714A1 · Feb 15, 2024
References Cited (292)
US 3686398A · Mcmurtry et al. · 1972 [cited by applicant]
US 3873279A · Singer · 1975 [cited by applicant]
US 4421774A · Vidal et al. · 1983 [cited by applicant]
US 4843956A · Lashlee · 1989 [cited by applicant]
US 5880188A · Austin et al. · 1999 [cited by applicant]
US 5958463A · Milne et al. · 1999 [cited by applicant]
US 6305148B1 · Bowden et al. · 2001 [cited by applicant]
US 7078546B2 · Piers et al. · 2006 [cited by applicant]
US 7119049B2 · Rieck et al. · 2006 [cited by applicant]
US 7176228B2 · Elbe et al. · 2007 [cited by applicant]
US 7179840B2 · Rieck et al. · 2007 [cited by applicant]
US 7208169B2 · Dunkel et al. · 2007 [cited by applicant]
US 7390806B2 · Lee et al. · 2008 [cited by applicant]
US 7393856B2 · Bellinger-Kawahara et al. · 2008 [cited by applicant]
US 7465836B2 · Lee et al. · 2008 [cited by applicant]
US 7582621B2 · Baker et al. · 2009 [cited by applicant]
US 7652000B2 · Perry et al. · 2010 [cited by applicant]
US 7767657B2 · Baker et al. · 2010 [cited by applicant]
US 7816344B2 · Baker et al. · 2010 [cited by applicant]
US 7842823B2 · Chang · 2010 [cited by applicant]
US 7888356B2 · Lee et al. · 2011 [cited by applicant]
US 7968752B2 · Lee et al. · 2011 [cited by applicant]
US 8039450B2 · Akama et al. · 2011 [cited by applicant]
US 8039451B2 · Baker et al. · 2011 [cited by applicant]
US 8106031B2 · Lee et al. · 2012 [cited by applicant]
US 8110259B2 · Siegel et al. · 2012 [cited by applicant]
US 8115026B2 · Baker et al. · 2012 [cited by applicant]
US 8168614B2 · Baker et al. · 2012 [cited by applicant]
US 8343944B2 · Xia et al. · 2013 [cited by applicant]
US 8436028B2 · Hunt et al. · 2013 [cited by applicant]
US 8440642B2 · Baker et al. · 2013 [cited by applicant]
US 8461134B2 · Hernandez et al. · 2013 [cited by applicant]
US 8461135B2 · Akama et al. · 2013 [cited by applicant]
US 8461336B2 · Zhou et al. · 2013 [cited by applicant]
US 8461364B2 · Wheeler et al. · 2013 [cited by applicant]
US 8470803B2 · Akama et al. · 2013 [cited by applicant]
US 8501712B2 · Baker et al. · 2013 [cited by applicant]
US 8546357B2 · Akama et al. · 2013 [cited by applicant]
US 8669207B1 · Jacobson et al. · 2014 [cited by applicant]
US 8791258B2 · Chang · 2014 [cited by applicant]
US 8906848B2 · Wuts et al. · 2014 [cited by applicant]
US 9138001B2 · Maclean et al. · 2015 [cited by applicant]
US 9138002B2 · Jacobson et al. · 2015 [cited by applicant]
US 9145429B2 · Jarnagin et al. · 2015 [cited by applicant]
US 9185914B2 · Frackenpohl et al. · 2015 [cited by applicant]
US 9309508B2 · Benkovic et al. · 2016 [cited by applicant]
US 9346834B2 · Zhou et al. · 2016 [cited by applicant]
US 9426996B2 · Maclean et al. · 2016 [cited by applicant]
US 9493489B2 · Jacobs et al. · 2016 [cited by applicant]
US 9493490B1 · Akama et al. · 2016 [cited by applicant]
US 9512148B2 · Chellappan et al. · 2016 [cited by applicant]
US 9572823B2 · Baker et al. · 2017 [cited by applicant]
US 9585396B2 · Malefyt et al. · 2017 [cited by applicant]
US 9617285B2 · Akama et al. · 2017 [cited by applicant]
US 9676796B2 · Kim et al. · 2017 [cited by applicant]
US 9730454B2 · Jacobson · 2017 [cited by applicant]
US 9737075B2 · Benkovic et al. · 2017 [cited by applicant]
US 9889146B2 · Alley et al. · 2018 [cited by applicant]
US 9944660B2 · Soni et al. · 2018 [cited by applicant]
US 10011616B2 · Zhang et al. · 2018 [cited by applicant]
US 10040806B2 · Rajan et al. · 2018 [cited by applicant]
US 10051864B2 · Stoller et al. · 2018 [cited by applicant]
US 10070649B2 · Malefyt et al. · 2018 [cited by applicant]
US 10159252B2 · Jacobson · 2018 [cited by applicant]
US 10765117B2 · Maclean et al. · 2020 [cited by applicant]
US 11039617B2 · Maclean et al. · 2021 [cited by applicant]
US 20040259842A1 · Mikoshiba et al. · 2004 [cited by applicant]
US 20070155699A1 · Baker et al. · 2007 [cited by applicant]
US 20070286822A1 · Sanders et al. · 2007 [cited by applicant]
US 20070293457A1 · Baker et al. · 2007 [cited by applicant]
US 20080153992A1 · Knott et al. · 2008 [cited by applicant]
US 20080293675A1 · Lee et al. · 2008 [cited by applicant]
US 20080317737A1 · Patel et al. · 2008 [cited by applicant]
US 20090148623A1 · Sandmeier et al. · 2009 [cited by applicant]
US 20090170861A1 · Ting et al. · 2009 [cited by applicant]
US 20090227541A1 · Baker et al. · 2009 [cited by applicant]
US 20090239824A1 · Lee et al. · 2009 [cited by applicant]
US 20090291917A1 · Akama et al. · 2009 [cited by applicant]
US 20100004205A1 · Mayer · 2010 [cited by applicant]
US 20100158992A1 · Black et al. · 2010 [cited by applicant]
US 20100190748A1 · Baker et al. · 2010 [cited by applicant]
US 20100256092A1 · Xia et al. · 2010 [cited by applicant]
US 20100267981A1 · Baker et al. · 2010 [cited by applicant]
US 20100292504A1 · Baker et al. · 2010 [cited by applicant]
US 20110059985A1 · Schmidts et al. · 2011 [cited by applicant]
US 20110076261A1 · Patel et al. · 2011 [cited by applicant]
US 20110082118A1 · Patel et al. · 2011 [cited by applicant]
US 20110123624A1 · Zasloff · 2011 [cited by applicant]
US 20110124597A1 · Hernandez et al. · 2011 [cited by applicant]
US 20110136763A1 · Xia et al. · 2011 [cited by applicant]
US 20110152217A1 · Wheeler et al. · 2011 [cited by applicant]
US 20110166103A1 · Akama et al. · 2011 [cited by applicant]
US 20110166104A1 · Zhou et al. · 2011 [cited by applicant]
US 20110172187A1 · Hernandez et al. · 2011 [cited by applicant]
US 20110183969A1 · Birch et al. · 2011 [cited by applicant]
US 20110190235A1 · Chen et al. · 2011 [cited by applicant]
US 20110207701A1 · Zhou et al. · 2011 [cited by applicant]
US 20110207702A1 · Jacobs et al. · 2011 [cited by applicant]
US 20110212918A1 · Hernandez et al. · 2011 [cited by applicant]
US 20110319361A1 · Baker et al. · 2011 [cited by applicant]
US 20120035132A1 · Jarnagin et al. · 2012 [cited by applicant]
US 20120115813A1 · Hernandez et al. · 2012 [cited by applicant]
US 20120214765A1 · Akama et al. · 2012 [cited by applicant]
US 20120264714A1 · Baker et al. · 2012 [cited by applicant]
US 20120289686A1 · Baker et al. · 2012 [cited by applicant]
US 20120295875A1 · Zhou et al. · 2012 [cited by applicant]
US 20130059802A1 · Baker et al. · 2013 [cited by applicant]
US 20130059803A1 · Baker et al. · 2013 [cited by applicant]
US 20130064783A1 · Baker et al. · 2013 [cited by applicant]
US 20130131016A1 · Akama et al. · 2013 [cited by applicant]
US 20130131017A1 · Akama et al. · 2013 [cited by applicant]
US 20130165411A1 · Gordeev et al. · 2013 [cited by applicant]
US 20130196433A1 · Raines et al. · 2013 [cited by applicant]
US 20130210770A1 · Baker et al. · 2013 [cited by applicant]
US 20130231304A1 · Jacobs et al. · 2013 [cited by applicant]
US 20130244980A1 · Baker et al. · 2013 [cited by applicant]
US 20130298290A1 · Haas et al. · 2013 [cited by applicant]
US 20130316979A1 · Baker et al. · 2013 [cited by applicant]
US 20140088041A1 · Koop et al. · 2014 [cited by applicant]
US 20140155305A1 · Hartshorne et al. · 2014 [cited by applicant]
US 20140259230A1 · Bobbio et al. · 2014 [cited by applicant]
US 20150202321A1 · Alam et al. · 2015 [cited by applicant]
US 20160199351A1 · Rappleye et al. · 2016 [cited by applicant]
US 20160340369A1 · Chen et al. · 2016 [cited by applicant]
US 20170000132A1 · Rajan et al. · 2017 [cited by applicant]
US 20170000133A1 · Rajan et al. · 2017 [cited by applicant]
US 20170037258A1 · Benkovic et al. · 2017 [cited by applicant]
US 20170042966A1 · Van Der Weerden et al. · 2017 [cited by applicant]
US 20170216327A1 · Coronado et al. · 2017 [cited by applicant]
US 20170251673A1 · Cifuentes et al. · 2017 [cited by applicant]
US 20170280724A1 · Jacobson · 2017 [cited by applicant]
US 20170295809A1 · Malefyt et al. · 2017 [cited by applicant]
US 20170319536A1 · Blaszczyk et al. · 2017 [cited by applicant]
US 20170327519A1 · Akama et al. · 2017 [cited by applicant]
US 20170340607A1 · Sibley et al. · 2017 [cited by applicant]
US 20170355719A1 · Hernandez et al. · 2017 [cited by applicant]
US 20180000089A1 · Stierli et al. · 2018 [cited by applicant]
US 20180000090A1 · Rajan et al. · 2018 [cited by applicant]
US 20180009831A1 · Kovi et al. · 2018 [cited by applicant]
US 20180016285A1 · Baker et al. · 2018 [cited by applicant]
US 20180065994A1 · Akama et al. · 2018 [cited by applicant]
US 20180139975A1 · Malefyt et al. · 2018 [cited by applicant]
US 20180179229A1 · Barbosa et al. · 2018 [cited by applicant]
US 20180179233A1 · Gamsey et al. · 2018 [cited by applicant]
US 20180201628A1 · James et al. · 2018 [cited by applicant]
US 20180213781A1 · Muehlebach et al. · 2018 [cited by applicant]
US 20180220654A1 · Jacobson et al. · 2018 [cited by applicant]
US 20180230169A1 · Ramanujachary et al. · 2018 [cited by applicant]
US 20180244699A1 · Rajan et al. · 2018 [cited by applicant]
US 20220361503A1 · MacLean et al. · 2022 [cited by applicant]
AU 2010203096A1 · 2010 [cited by applicant]
AU 2012327171A1 · 2013 [cited by applicant]
AU 2012327230A1 · 2013 [cited by applicant]
CA 2190155A1 · 1995 [cited by applicant]
CA 2635680A1 · 2007 [cited by applicant]
CA 2642583A1 · 2007 [cited by applicant]
CA 2680587A1 · 2008 [cited by applicant]
CN 101505603A · 2009 [cited by applicant]
DE 102012006458A1 · 2013 [cited by applicant]
EP 765331A1 · 1997 [cited by applicant]
EP 1444981A1 · 2004 [cited by applicant]
EP 1765358A2 · 2007 [cited by applicant]
EP 1765360A2 · 2007 [cited by applicant]
EP 1980564A1 · 2008 [cited by applicant]
EP 2343304A1 · 2011 [cited by applicant]
EP 2564857A1 · 2013 [cited by applicant]
GB 961280A · 1964 [cited by applicant]
GB 1006336A · 1965 [cited by applicant]
GB 1396904A · 1975 [cited by applicant]
WO 9531970A1 · 1995 [cited by applicant]
WO 9533754A1 · 1995 [cited by applicant]
WO 9821945A1 · 1998 [cited by applicant]
WO 2005087742A1 · 2005 [cited by applicant]
WO 2006089067A2 · 2006 [cited by applicant]
WO 2006102604A2 · 2006 [cited by applicant]
WO 2007071632A2 · 2007 [cited by applicant]
WO 2007078340A2 · 2007 [cited by applicant]
WO 2007079119A2 · 2007 [cited by applicant]
WO 2007095638A2 · 2007 [cited by applicant]
WO 2007131072A2 · 2007 [cited by applicant]
WO 2007146965A2 · 2007 [cited by applicant]
WO 2008064345A2 · 2008 [cited by applicant]
WO 2008070257A2 · 2008 [cited by applicant]
WO 2008115385A2 · 2008 [cited by applicant]
WO 2008156798A1 · 2008 [cited by applicant]
WO 2008157726A1 · 2008 [cited by applicant]
WO 2009046098A1 · 2009 [cited by applicant]
WO 2009053741A2 · 2009 [cited by applicant]
WO 2009111676A2 · 2009 [cited by applicant]
WO 2009130481A1 · 2009 [cited by applicant]
WO 2009140309A2 · 2009 [cited by applicant]
WO 2009144473A1 · 2009 [cited by applicant]
WO 2010027975A1 · 2010 [cited by applicant]
WO 2010028005A1 · 2010 [cited by applicant]
WO 2010045503A1 · 2010 [cited by applicant]
WO 2010045505A1 · 2010 [cited by applicant]
WO 2010080558A1 · 2010 [cited by applicant]
WO 2010136475A1 · 2010 [cited by applicant]
WO 2011017125A1 · 2011 [cited by applicant]
WO 2011019612A1 · 2011 [cited by applicant]
WO 2011019616A1 · 2011 [cited by applicant]
WO 2011019618A1 · 2011 [cited by applicant]
WO 2011022337A1 · 2011 [cited by applicant]
WO 2011037731A1 · 2011 [cited by applicant]
WO 2011043817A1 · 2011 [cited by applicant]
WO 2011049971A1 · 2011 [cited by applicant]
WO 2011060196A1 · 2011 [cited by applicant]
WO 2011060199A1 · 2011 [cited by applicant]
WO 2011063293A1 · 2011 [cited by applicant]
WO 2011094450A1 · 2011 [cited by applicant]
WO 2011116348A1 · 2011 [cited by applicant]
WO 2011150190A2 · 2011 [cited by applicant]
WO 2012033858A2 · 2012 [cited by applicant]
WO 2012067663A1 · 2012 [cited by applicant]
WO 2012069652A2 · 2012 [cited by applicant]
WO 2012139134A2 · 2012 [cited by applicant]
WO 2012154213A1 · 2012 [cited by applicant]
WO 2013033270A2 · 2013 [cited by applicant]
WO 2013050591A2 · 2013 [cited by applicant]
WO 2013057740A2 · 2013 [cited by applicant]
WO 2013058824A1 · 2013 [cited by applicant]
WO 2013078070A1 · 2013 [cited by applicant]
WO 2013078071A1 · 2013 [cited by applicant]
WO 2013093615A1 · 2013 [cited by applicant]
WO 2013108024A1 · 2013 [cited by applicant]
WO 2013110005A1 · 2013 [cited by applicant]
WO 2013154759A1 · 2013 [cited by applicant]
WO 2015097237A1 · 2015 [cited by applicant]
WO 2016015094A1 · 2016 [cited by applicant]
WO 2016151293A1 · 2016 [cited by applicant]
WO 2017102565A1 · 2017 [cited by applicant]
WO 2017125835A1 · 2017 [cited by applicant]
WO 2017136930A1 · 2017 [cited by applicant]
WO 2017180695A1 · 2017 [cited by applicant]
WO 2017183043A1 · 2017 [cited by applicant]
WO 2017207358A1 · 2017 [cited by applicant]
WO 2017216191A1 · 2017 [cited by applicant]
WO 2017216722A2 · 2017 [cited by applicant]
WO 2018060140A1 · 2018 [cited by applicant]
WO 2018102261A2 · 2018 [cited by applicant]
WO 2018156554A1 · 2018 [cited by applicant]
WO 2018160845A1 · 2018 [cited by applicant]
Pubchem entry for AN2718 (https://pubchem.ncbi.nlm.nih.gov/compound/11845944) accessed Mar. 1, 2020. [cited by applicant]
Dauthy, “Fruit and Vegetable processing: Chapter 5.3 Chemical Preservation,” FAO Argricultural Services Bulletin, 1995, 119. [cited by applicant]
Reddy et al, “1-MCP, a novel plant growth regulator for regulation of ripening,” Agricultural & Horticultural Sciences, 2014. [cited by applicant]
Seiradake E, et al., “Antifungal activity and mechanism of action of a benzoxaborole, AN2718, which is in development for the treatment of Tinea pedis,” Abstract F1-1176, IDSA Poster Session: New Anti-Fungal Agents (200… [cited by applicant]
Mao W, et al., “AN2718 has broad spectrum antifungal activity necessary for the topical treatment of skin and nail fungal infections,” Abstract p. 2422, J. American Acad. Dermatology 60(3) Supplement 1, AB116 (2009). [cited by applicant]
Rolshausen PE, et al., “Use of boron for the control of Eutypa dieback of grapevines,” Plant Diseases 89(7): 734-738 (2005). [cited by applicant]
Qin G, et al., “Inhibitory effect of boron against Botrytis cinerea on table grapes and its possible mechanisms of action,” International Journal of Food Microbiology 138: 145-150 (2010). [cited by applicant]
Thomidis T and Exadaktylou E., “Effect of boron on the development of brown rot ( [cited by applicant]
Expert Declaration of Phillip M. Brannen, Ph.D., filed in an Inter Partes Review of U.S. Pat. No. 10,130,096, filed Nov. 5, 2019. [cited by applicant]
Boric Acid, Chemical Watch Factsheet, 21, 18-19 (2001). [cited by applicant]
Ligon JM, et al, “Natural products with antifungal activity from Pseudomonas biocontrol bacteria,” Pest Management Science 56: 688-695 (2000). [cited by applicant]
Alumni Product Registration (Jun. 9, 2010). [cited by applicant]
Propi-Shield Product Registration (Aug. 11, 2005). [cited by applicant]
Tilt Label (2006). [cited by applicant]
Mahmoud Yag, et al., “Recent approaches for controlling brown spot disease of faba bean in Egypt,” Egypt Acad. J. Biol. Sci. 3: 41-53 (2011). [cited by applicant]
Ware G, “Substituted aromatics,” pp. 148-149, In: Fundamentals of Pesticides: a self-instruction guide, Tomson Publications, Fresno, CA (1991). [cited by applicant]
Bertelsen JR, et al., “Fungicidal effects of azoxystrobin and epoxiconazole on phyllosphere fungi, senescence and yield of winter wheat,” Plant Pathology 50: 190-205 (2001). [cited by applicant]
Propi-Shield Label Amendment (Nov. 29, 2006). [cited by applicant]
Azotech Label Amendment (Sep. 7, 2007). [cited by applicant]
PptiShield Label (2009). [cited by applicant]
Abound label (2007). [cited by applicant]
Chlorosel label (2010). [cited by applicant]
Ultrex label (2005). [cited by applicant]
Chloroneb Fact Sheet (2005). [cited by applicant]
Dichloran Label Amendment (Aug. 5, 2010). [cited by applicant]
Expert Declaration of Dennis Hall, Ph.D. filed in an Inter Partes Review of U.S. Pat. No. 10,130,096, filed Nov. 5, 2019. [cited by applicant]
Patent Owner Preliminary Response filed in an Inter Partes Review of U.S. Pat. No. 10,130,096, filed Feb. 18, 2020. [cited by applicant]
Dictionary Reference filed in an Inter Partes Review of U.S. Pat. No. 10,130,096. [cited by applicant]
Petition for Inter Partes Review of U.S. Pat. No. 10,130,096, filed Nov. 5, 2019. [cited by applicant]
Marsh et al., J. Good Sc. 2007, vol. 72, R39-R54. [cited by applicant]
Rock, F.L.W. Matoe, et al., “An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site,” Science 316, 2007, 1759-1761. [cited by applicant]
Edwards, “Organoboron reagents and recent strategies in rhodium catalysed additions,” Ph. D. Thesis submitted to University of Bath, 2011, pp. 1-293. [cited by applicant]
Ma, X. et al., “Synthesis of Boroxine-Linked Aluminium Complexes,” Inorg. Chem., 2011, 50, 2010-2014. [cited by applicant]
Alexander, C. et al., “Imprinted Polymers as Protecting Groups for Regioselective Modifcation of Polyfunctional Substrates,” J. Am. Chem. Soc., 1999, 121 , 6640-6651. [cited by applicant]
Greig, L. et al., “The dynamic covalent chemistry of mono- and bifunctional boroxoaromatics”, Tetrahedron, 2006, 63, 2391-2403. [cited by applicant]
Weike, Z. et al.,“Preparation of 2-oxygen derivatives of 1,2-oxaborolane from 2-allyloxy-1,2-oxaborolane,” Journal of Organometallic Chemistry, 1990, 387, 131-146. [cited by applicant]
Office Action for Japanese Patent Application No. 2016-517975, dated Dec. 24, 2019, 4 pages. [cited by applicant]
Kumar, J.S. et al., “Development of Practical Methodologies for the Synthesis of Functionalized Benzoboroxoles”, Tetrahendron Letters, Elsevier, Amsterdam, NL, col. 51, No. 34, Aug. 24, 2010, pp. 4482-4485. [cited by applicant]
Mao, W., “AN2690, a topical antifungal agent in development for the treatment of onychmycosis represents a new class and has a novel mechanism of action”, Anacor Pharmaceuticals AG, Aug. 20, 2008, XP007921849, www.anaco… [cited by applicant]
Ding et al., “Design, Synthesis, and Structure—Activity Relationship of Trypanosoma brucei Leucyl-tRNA Synthetase Inhibitors as Antitrypanosomal Agents,” J. Med. Chem. (2011), vol. 54(5), pp. 1276-1287. [cited by applicant]
Haynes et al., “Arylboronic Acids. Villl. Reactions of Boronophthalide”, Noyes Chemical Laboratory, University of Illinois, Nov. 1964, pp. 3229-3233 Urbana, USA (5 pages). [cited by applicant]
Brown et al., “Convenient Procedures for the Preparation of Alkyl Borate Esters,” Proc. for Prepn. Alkyl Borate Esters, Aug. 5, 1956, pp. 3613-3614. [cited by applicant]
Shen et al., “Changes of respiration and ethylene production and effects of 1-MCP during the fermentation softening of chinese winter jujube fruit,” Zhongguo Nongye Daxue Xuebao (2004) vol. 9(2), pp. 36-39. [cited by applicant]
Guillen et al., “Efficacy of 1-MCP treatment in tomato fruit 2. Effect of cultivar and ripening stage at harvest,” Postharvest Biology and Technol. (2006) vol. 42(3), pp. 235-242. [cited by applicant]
Carillo et al., “1-Methylcyclopropene delays araze a ripening and improves postharvest fruit quality,” LWT—Food Sci. and Tech. (2011) vol. 44, pp. 250-255. [cited by applicant]
International Search Report for PCT/US2014/013510, Dow AgroSciences LLC, Jun. 25, 2014. [cited by applicant]
Brown et al. Proc. for Prepn. Alkyl Borate Esters, (1956), pp. 3613-3614. [cited by applicant]
Baker, Stephen et al., Discovery of new boron-containing antifungal agent, 5-fluoro-1,3,dihydroxy-2-1-benzoxabrole (AN2690), for the potential treatment of onychomycosis, Journal of Medicinal Chemistry, Jul. 1, 2006, 49… [cited by applicant]
“Smart Fog ES-100 models Installation and Operation Manual”, Jan. 1, 2012 (Jan. 1, 2012), pp. 1-30, XP055724760, U.S.A., Retrieved from the Internet: URL:https://www.smartfog.com/pdf/mn_es100.pdf [retrieved on Aug. 24, … [cited by applicant]
EPO Examination Report for Application No. 17763834.3, dated Aug. 31, 2020 (Aug. 31, 2020) 10 pages. [cited by applicant]